Document is current
Any future updates will be listed below
-
Authors
Haberman, Rebecca H. https://orcid.org/0000-0002-7119-8136
Ogdie, Alexis
Merola, Joseph F.
Scher, Jose U.
Eder, Lihi https://orcid.org/0000-0002-1473-1715
- License Information
-
More Information
Article History
Accepted: 31 October 2025
First Online: 24 November 2025
Competing interests
: R.H.H. has served as a consultant to Johnson & Johnson and Novartis. A.O. has received grant support from AbbVie, Johnson & Johnson, Novartis and Pfizer, and to Forward database from Amgen and Bristol Myers Squibb; and has served as a consultant fees from AbbVie, Amgen, Bristol Myers Squibb, Celgene, CorEvitas, Lilly, Gilead, Happify, Janssen, Novartis, Pfizer and UCB. J.F.M. has received personal fees from AbbVie, Amgen, AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, Dermavant, Janssen, Lilly, Moonlake, UCB and Novartis; and has received grants from Pfizer and Sun Pharma. J.U.S. has served as a consultant for AbbVie, Johnson & Johnson, Kaleido, Novartis, Pfizer, Sanofi and UCB; and has received funding for investigator-initiated studies from Johnson & Johnson, Novartis, and Pfizer. L.E. has received grants from AbbVie, Pfizer, Johnson & Johnson, UCB, Novartis and Lilly.
